Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases - Wikidata - wikimedia - TriplyDB

Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases

Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases

http://www.wikidata.org/entity/Q37709623

about

Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect A potent multivalent vaccine for modulation of immune system in atherosclerosis: an in silico approach

P2860

Q28553042-FA27FAD1-E59E-49B3-A353-AB4E58C8885E Q36547962-5A3BE651-BF70-40A7-BAF2-B307382FF886

P2860

Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases

http://www.wikidata.org/entity/Q37709623

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases

@en

Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases.

@nl

type

label

Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases

@en

Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases.

@nl

prefLabel

Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases

@en

Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases.

@nl

P1433

Q37709623-3F29B171-5802-4991-84D1-A6FF2FE9731C

P1476

Q37709623-F4408B1F-3C63-4BD8-A956-517D26E4D0B6

P2093

Q37709623-51A13327-8DF5-4B3B-8AE6-11E5303BB4A2

Q37709623-94B8F6A2-5F22-44E3-8CBB-567634E7021E

P2860

Q37709623-05C65BC7-8C34-45CA-9BCB-717D4F5C7980

Q37709623-0AC65D89-6432-4B9F-893C-9D13288FA8B0

Q37709623-163F73AB-D21B-4974-9289-792C23370788

Q37709623-1E99D01C-EAC7-4D09-BB9C-2E0515B3735D

Q37709623-1F0B0D7C-E44B-4CDA-9D83-DF6B7DCC675F

Q37709623-2225F866-616E-46E4-B236-68FB89F777C2

Q37709623-23D8CD10-D95B-4E89-B1AC-8E29ED5F1257

Q37709623-262872B8-1B97-424A-B55A-13651F8DB9B8

Q37709623-290B9B5A-77C4-4C1B-9D26-3D976E541C80

Q37709623-2C08A596-8549-4A74-8FF0-D9668EE7EF98

P304

Q37709623-63659EAE-970B-49A6-96DC-C21E25867049

P31

Q37709623-FB3776BA-5ACD-4099-94D8-2552C1916A26

P356

Q37709623-2914FC69-D695-4059-9E27-059A66BA7CF7

P433

Q37709623-41A13071-DD39-460C-8A27-42D732A39E03

P478

Q37709623-FE96A2AC-E6AB-479B-B595-B95BB8BD98D9

P577

Q37709623-B67F10CC-63A3-41B6-8B2E-E0D73FE95A60

P698

Q37709623-92ACDBAB-22DC-4A87-87B7-870B090E2ABB

P921

Q37709623-21285012-BAA0-46B4-B2C4-E1D4A20ADF10

Q37709623-36688E76-3912-414B-A376-A77155B03128

P932

Q37709623-5D386745-5E70-4007-A2FD-752E5814A416

P356

2051013613514327

P1433

Therapeutic advances in vaccines

P1476

Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseases

@en

P2093

Kuang-Yuh Chyu

http://www.w3.org/2001/XMLSchema#string

Prediman K Shah

http://www.w3.org/2001/XMLSchema#string

P2860

Induction of immunological tolerance by oral anti-CD3

Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formation

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions

CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide

Cancer immunotherapy via dendritic cells

Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease.

Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences.

LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis.

Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis.

P304

56-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2051013613514327

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24757525

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

cardiovascular disease

P932

3991155

http://www.w3.org/2001/XMLSchema#string